Latest Insider Transactions at Aadi Bioscience, Inc. (AADI)
This section provides a real-time view of insider transactions for Aadi Bioscience, Inc. (AADI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aadi Bioscience, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aadi Bioscience, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2022
|
Neil Desai EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
3,550
-0.19%
|
$71,000
$20.07 P/Share
|
|
Aug 26
2021
|
Anupam Dalal |
BUY
Open market or private purchase
|
Indirect |
1,529,402
+50.0%
|
$19,882,226
$13.08 P/Share
|
|
Aug 26
2021
|
Caley Castelein |
BUY
Open market or private purchase
|
Indirect |
259,998
+50.0%
|
$3,379,974
$13.08 P/Share
|
|
Aug 26
2021
|
Behzad Aghazadeh |
BUY
Grant, award, or other acquisition
|
Indirect |
1,911,752
+46.36%
|
$24,852,776
$13.08 P/Share
|
|
Jun 30
2021
|
Cheryl Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,140
+33.5%
|
$8,140
$1.52 P/Share
|
|
Jun 30
2021
|
Caley Castelein |
BUY
Grant, award, or other acquisition
|
Direct |
7,811
+2.58%
|
$7,811
$1.52 P/Share
|
|
Jun 30
2021
|
Pravin Dugel Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,331
+33.5%
|
$6,331
$1.52 P/Share
|
|
Jun 30
2021
|
Steven Prelack Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,334
+33.5%
|
$12,334
$1.52 P/Share
|
|
Jun 30
2021
|
Anupam Dalal |
BUY
Grant, award, or other acquisition
|
Direct |
7,400
+30.38%
|
$7,400
$1.52 P/Share
|
|
Mar 31
2021
|
Caley Castelein |
BUY
Grant, award, or other acquisition
|
Direct |
7,696
+2.61%
|
$7,696
$1.54 P/Share
|
|
Mar 31
2021
|
Steven Prelack Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,151
+50.0%
|
$12,151
$1.54 P/Share
|
|
Mar 31
2021
|
Pravin Dugel Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,237
+50.0%
|
$6,237
$1.54 P/Share
|
|
Mar 31
2021
|
Anupam Dalal |
BUY
Grant, award, or other acquisition
|
Direct |
7,290
+43.27%
|
$7,290
$1.54 P/Share
|
|
Mar 31
2021
|
Cheryl Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,020
+50.0%
|
$8,020
$1.54 P/Share
|
|
Dec 08
2020
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,400
-100.0%
|
$21,400
$1.96 P/Share
|
|
Dec 08
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
21,400
+50.0%
|
$0
$0.96 P/Share
|
|
Apr 26
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
138,704
-3.31%
|
$138,704
$1.03 P/Share
|
|
Apr 25
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
563,096
-11.85%
|
$563,096
$1.03 P/Share
|
|
Apr 24
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,403
-0.34%
|
$16,403
$1.03 P/Share
|
|
Apr 23
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,554
-0.57%
|
$27,554
$1.03 P/Share
|
|
Apr 22
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,100
-0.15%
|
$0
$0.97 P/Share
|
|
Apr 15
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,794
-0.6%
|
$0
$0.99 P/Share
|
|
Apr 12
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,908
-0.64%
|
$30,908
$1.04 P/Share
|
|
Apr 11
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
57,438
-1.17%
|
$57,438
$1.08 P/Share
|
|
Apr 10
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
140,230
-2.77%
|
$140,230
$1.09 P/Share
|
|
Apr 09
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,991
-0.65%
|
$32,991
$1.01 P/Share
|
|
Apr 08
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,525
-0.54%
|
$27,525
$1.02 P/Share
|
|
Apr 05
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,661
-0.48%
|
$24,661
$1.02 P/Share
|
|
Apr 04
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
47,900
-0.92%
|
$47,900
$1.01 P/Share
|
|
Apr 03
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
58,033
-1.11%
|
$0
$0.96 P/Share
|
|
Apr 02
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,754
-0.98%
|
$0
$0.97 P/Share
|
|
Apr 01
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
116,909
-2.16%
|
$0
$0.95 P/Share
|
|
Mar 29
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
63,100
-1.15%
|
$0
$0.91 P/Share
|
|
Mar 28
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
88,835
-1.59%
|
$0
$0.94 P/Share
|
|
Mar 27
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,749
-0.9%
|
$0
$0.99 P/Share
|
|
Mar 26
2019
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
177,762
-3.06%
|
$177,762
$1.01 P/Share
|
|
Aug 20
2018
|
Novartis Bioventures LTD > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,300
-0.09%
|
$15,900
$3.9 P/Share
|
|
Jun 28
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
777,500
+13.02%
|
$2,332,500
$3.85 P/Share
|
|
Mar 15
2017
|
Novartis Bioventures LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
560,000
+8.8%
|
$2,800,000
$5.0 P/Share
|